Market Value365,729,922
Total Holdings73
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
SPRO / Spero Therapeutics, Inc.
PRDS / Pardes Biosciences Inc
GNFT / Genfit S.A.
IKNA / Ikena Oncology, Inc.
/ THESEUS PHARMACEUTICALS INC
RVMD / Revolution Medicines, Inc.
APLS / Apellis Pharmaceuticals, Inc.
MDNA / Medicenna Therapeutics Corp
DICE / DICE Therapeutics Inc
LYRA / Lyra Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
CSII / Cardiovascular Systems Inc.
VIGL / Vigil Neuroscience, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
ACRV / Acrivon Therapeutics, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
LRMR / Larimar Therapeutics, Inc.
ISEE / IVERIC bio Inc
REUN / Reunion Neuroscience Inc
VKTX / Viking Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
EWTX / Edgewise Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ARAY / Accuray Incorporated
STRO / Sutro Biopharma, Inc.
PRQR / ProQR Therapeutics N.V.
SPRB / Spruce Biosciences, Inc.
NRIX / Nurix Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
DXCM / DexCom, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
STIM / Neuronetics, Inc.
ELEV / Elevation Oncology, Inc.
TNDM / Tandem Diabetes Care, Inc.
NBIX / Neurocrine Biosciences, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
SURF / Surface Oncology Inc
ATXS / Astria Therapeutics, Inc.
ACET / Adicet Bio, Inc.
CGEN / Compugen Ltd.
IBB / iShares Trust - iShares Biotechnology ETF
BHVN / Biohaven Ltd.
KRTX / Karuna Therapeutics, Inc.
NVRO / Nevro Corp.
TSVT / 2seventy bio, Inc.
NXTC / NextCure, Inc.
MRSN / Mersana Therapeutics, Inc.
AXGN / Axogen, Inc.
SYRS / Syros Pharmaceuticals, Inc.
KNTE / Kinnate Biopharma Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
SAGE / Sage Therapeutics, Inc.
MORF / Morphic Holding, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ATRC / AtriCure, Inc.
XENE / Xenon Pharmaceuticals Inc.
IDYA / IDEAYA Biosciences, Inc.
RCUS / Arcus Biosciences, Inc.
INGN / Inogen, Inc.
PRCT / PROCEPT BioRobotics Corporation
DAWN / Day One Biopharmaceuticals, Inc.
STXS / Stereotaxis, Inc.
KURA / Kura Oncology, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
BCRX / BioCryst Pharmaceuticals, Inc.
ALEC / Alector, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
MASI / Masimo Corporation
KPTI / Karyopharm Therapeutics Inc.
CMPX / Compass Therapeutics, Inc.
MDWD / MediWound Ltd.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
RGLS / Regulus Therapeutics Inc.